Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Colorectal Screening Rates Increase
Health
May 4, 2026 Evan Vega

Colorectal Cancer Screening Rates Surge Among 45-49 Year Olds Following USPSTF Guidelines

Colorectal cancer screening rates rose significantly among insured adults aged 45-49 after USPSTF lowered the recommended screening age in 2021.

Read More
AMA combats physician deepfakes
Health
May 4, 2026 Evan Vega

AMA Issues Policy Framework to Combat AI Deepfakes Impersonating Physicians

The AMA released a policy framework to combat AI deepfakes impersonating physicians, enhancing identity protections and addressing legal gaps.

Read More
White House speeds mental healthcare
Health
May 4, 2026 Evan Vega

White House Orders Acceleration of Medical Treatments for Serious Mental Illness

President Trump signed an executive order to expedite FDA approval of psychedelic drugs for serious mental illness treatment in the U.S.

Read More
Intensive Blood Pressure Safety
Health
May 3, 2026 Evan Vega

Chinese Trial Finds Intensive Blood Pressure Control Below 120 mm Hg Safe for Cognitive Function in 11,000 Hypertension Patients

A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.

Read More
Safety Clinics Expand Heat
Health
May 3, 2026 Evan Vega

Safety-Net Clinics Expand Heat Action Plans to Combat Extreme Heat Impacts on Vulnerable Populations

Safety-net clinics nationwide expanded heat action plans this summer to protect vulnerable populations from extreme heat-related health risks.

Read More
AMA AI Deepfake Protection
Health
May 3, 2026 Evan Vega

AMA Unveils Policy Framework to Protect Physicians from AI Deepfake Impersonations

The AMA introduced a policy framework to prevent AI deepfake impersonations of physicians and protect patient safety.

Read More
Erasca Pill Shrinks Tumors
Health
April 29, 2026 Evan Vega

Erasca’s RAS-Targeting Pill Shrinks Tumors in 40% of Advanced Pancreatic Cancer Patients, 62% in Lung Cancer Cases

Erasca’s experimental pan-RAS pill shrank tumors in 40% of advanced pancreatic and 62% of non-small cell lung cancer patients in trials.

Read More
AMA Medicare Advantage Updates
Health
April 28, 2026 Evan Vega

AMA Secures Key Wins in CY 2027 Medicare Advantage Final Rule for Physicians

The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.

Read More
Pennsylvania Health Committee Vote
Health
April 28, 2026 Evan Vega

Pennsylvania Health Committee Votes on HB 916 in Latest Session

The Pennsylvania House Health Committee voted on HB 916 to update childhood blood lead testing requirements statewide.

Read More
National Summit on Opioids
Health
April 27, 2026 Evan Vega

Physicians Convene National Rx and Illicit Drug Summit to Combat Opioid Crisis

Over 2,500 physicians and addiction experts gathered in Atlanta for the 13th annual Rx and Illicit Drug Summit to address the opioid crisis.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.